Similar improvements are observed in immunopeptidomics. Bruker expects to launch the new AIP on the timsTOF Ultra 2 system at ASMS 2025 with timsTOF Ultra 2 field upgradability. B. DeutEx ...
timsTOF was engineered by Bruker experts as an open platform to accelerate the adoption of ion mobility-mass spectrometry analysis across research applications. All that is missing are your ...
As it happens, Bruker issued 9.5% more new shares over the last year. That means its earnings are split among a greater number of shares. Per share metrics like EPS help us understand how much ...
Ihre Namen: timsTOF HT (l.) und timsTOF Ultra2 (r ... Uni Wien wird von David Gómez-Varela geleitet und hat die Firma Bruker als Industriepartner.
In this article, we are going to take a look at where Bruker Corporation (NASDAQ:BRKR) stands against the other medical technology stocks. The MedTech sector is crucial in healthcare, which ...
The P2 technology delivers up to 7,000 protein identifications and quantifications in human plasma, using Biognosys’ breakthrough offering on the Bruker timsTOF® HT platform, setting new ...
The Price to Earnings (P/E) ratio, a key valuation measure, is calculated by dividing the stock's most recent closing price by the sum of the diluted earnings per share from continuing operations ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results
Feedback